Emicizumab versus immunosuppressive therapy for the management of ac-quired hemophilia A.

Hart C, Klamroth R, Sachs UJ, Greil R, Knoebl P, Oldenburg J, Miesbach W, Pfrepper C, Trautmann-Grill K, Pekrul I, Holstein K, Eichler H, Weigt C, Schipp D, Werwitzke S, Tiede A. J Thromb Haemost. 2024 Jun 25:S1538-7836(24)00368-4. doi: 10.1016/j.jtha.2024.06.010. Online ahead of print. PMID: 38936699.

Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer Patients.

Parigger T, Gassner FJ, Drothler S, Scherhäufl C, Hödlmoser A, Schultheis L, Bakar AA, Huemer F, Greil R, Geisberger R, Weiss L, Zaborsky N. Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241252706. doi: 10.1177/15330338241252706. PMID: 38766867.

Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer – a retrospective analysis.

Piringer G, Ponholzer F, Thaler J, Bachleitner-Hofmann T, Rumpold H, de Vries A, Weiss L, Greil R, Gnant M, Öfner D. Front Oncol. 2024 May 16;14:1374592. doi: 10.3389/fonc.2024.1374592. eCollection 2024. PMID: 38817890.

Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.

Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger B, Steiner T, Roghmann F, Niegisch G, Bolenz C, Schmitz M, Baretton G, Leucht K, Schumacher U, Foller S, Zengerling F, Meran J; TITAN-TCC Study Group. JAMA Oncol. 2024 May 9:e240938. doi: 10.1001/jamaoncol.2024.0938. Online ahead of print. PMID: 38722641.

Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?

Wimmer K, Hlauschek D, Balic M, Pfeiler G, Greil R, Singer CF, Halper S, Steger G, Suppan C, Gampenrieder SP, Helfgott R, Egle D, Filipits M, Jakesz R, Sölkner L, Fesl C, Gnant M, Fitzal F. Breast Cancer Res Treat. 2024 May 5. doi: 10.1007/s10549-024-07351-5. Online ahead of print. PMID: 38704775.

Oncogenic MTOR signaling axis compensates BTK inhibition in a Chronic Lymphocy-tic Leukemia patient with Richter Transformation: A Case Report and Review of the Literature.

Parigger T, Drothler S, Scherhäufl C, Gassner FJ, Schubert M, Steiner M, Höpner JP, Hödlmoser A, Schultheis L, Abu Bakar A, Neureiter D, Pleyer L, Egle A, Greil R, Geisberger R, Zaborsky N. Acta Haematol. 2024 Feb 24. doi: 10.1159/000537791. Online ahead of print. PMID: 38402867.

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy.

Lafarge MW, Domingo E, Sirinukunwattana K, Wood R, Samuel L, Murray G, Richman SD, Blake A, Sebag-Montefiore D, Gollins S, Klieser E, Neureiter D, Huemer F, Greil R, Dunne P, Quirke P, Weiss L, Rittscher J, Maughan T, Koelzer VH. NPJ Precis Oncol. 2024 Apr 9;8(1):89. doi: 10.1038/s41698-024-00580-3. PMID: 38594327.

Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials.

Kiem D, Ocker M, Greil R, Neureiter D, Melchardt T. Expert Opin Investig Drugs. 2024 Feb 23:1-14. doi: 10.1080/13543784.2024.2319317. Online ahead of print. PMID: 38354028.

Comment on: Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma.

Huemer F, Weiss L, Regitnig P, Winder T, Schmitt CA, Thaler J, Wöll E, Greil R. ESMO Open. 2024 Mar 19;9(4):102973. doi: 10.1016/j.esmoop.2024.102973. Online ahead of print. PMID: 38507896.

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus con-current chemoradiotherapy in patients with locally advanced squamous cell car-cinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.

Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Lancet Oncol. 2024 Mar 29:S1470-2045(24)00100-1. doi: 10.1016/S1470-2045(24)00100-1. Online ahead of print. PMID: 38561010.